Skip to main content

OP/Bone

RT @VeenaRheumMD: Dr. Lane on Ca/Vitamin D in Osteoporosis
⭐️🎯serum vitamin D 25OH ~38
⭐️Studies since 2008

Veena Katikineni VeenaRheumMD

9 months 1 week ago
Dr. Lane on Ca/Vitamin D in Osteoporosis ⭐️🎯serum vitamin D 25OH ~38 ⭐️Studies since 2008 Auckland Calcium trial DO NOT support incr CV risk with Ca supplementation ⭐️Ca calculator: https://t.co/PLPMfZdIwb⭐️No sig change in fracture risk with supp #ACR21 #ACRAmbassador https://t.co/KUa52vf4gT
RT @RichardPAConway: Dr Adachi presents ⬆️BMD gain with denosumab than risedronate in RA. Non-significant reduction

Richard Conway RichardPAConway

9 months 1 week ago
Dr Adachi presents ⬆️BMD gain with denosumab than risedronate in RA. Non-significant reduction in fractures (very small numbers) Interesting, but need to see fracture benefit in larger study to justify dmab as first line Abstr#0445 #ACR21 @RheumNow https://t.co/GgaS9JZGzb
RT @synovialjoints: A meta-analysis of 5 cohort studies showed that PsA is significantly associated with vertebral fract

Dr. Antoni Chan synovialjoints

9 months 1 week ago
A meta-analysis of 5 cohort studies showed that PsA is significantly associated with vertebral fractures pooled OR 2.09 (95% CI, 1.11 – 3.96; I2 70%). The review was not suggestive of publication bias @RheumNow #ACR21 Abst#1304 https://t.co/rjC776FXUA https://t.co/QvMWxN6ZZ7
RT @RichardPAConway: Meta-analysis shows increased risk of vertebral fracture in PsA, OR 2.09. Abstr#1304 #ACR21 @RheumN

Richard Conway RichardPAConway

9 months 1 week ago
Meta-analysis shows increased risk of vertebral fracture in PsA, OR 2.09. Abstr#1304 #ACR21 @RheumNow https://t.co/kTrR7I3HA0
RT @ericdeinmd: #ACR21 A#0563 - Is FRAX score applicable for RA? 10 yr Olmsted County epi study: Yes
▶️ 76 osteoporo

Eric Dein ericdeinmd

9 months 1 week ago
#ACR21 A#0563 - Is FRAX score applicable for RA? 10 yr Olmsted County epi study: Yes ▶️ 76 osteoporotic fxs in RA pts, FRAX predicted 67 fx (SIR 1.13, not signif) ▶️ 21 observed hip fx, FRAX predicted 23.3 (SIR 0.9) ⭐️ No differences by ages/sexhttps://t.co/vWy7EmseZp @Rheumnow https://t.co/8BlzgQYqaV
RT @ericdeinmd: @jhrheumatology Dr. Petri at #ACR21 Great Debate.
Safety issues with Voclosporin:
1) Nephrotoxicity
2) I

Eric Dein ericdeinmd

9 months 1 week ago
@jhrheumatology Dr. Petri at #ACR21 Great Debate. Safety issues with Voclosporin: 1) Nephrotoxicity 2) Infection 3) CV Risk Factors 4) Malignancy 5) Neurologic toxicity 6) Osteoporosis 7) Drug interactions 8) Deaths 9) Pregnancy contraindication @RheumNow https://t.co/wjluivmKNt
×